Jeffrey Chodakewitz
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Praxis Precision Announces Inducement Grants Under Nasdaq Rule. Praxis Precision Medicines disclosed that it will issue inducement grants under Nasdaq Listing Rule 5635(c)(4). This move is a compliance measure aimed at meeting Nasdaq’s shareholder requirements and may affect the company’s share structure. The announcement is a routine regulatory update rather than a new product or earnings event.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Adicet Bio shares positive Phase 1 lupus data, Wedbush lifts target. Adicet Bio announced that its Phase 1 study of Prula‑cel in lupus patients showed positive safety and efficacy signals, and the company is moving forward with plans for a pivotal trial. Wedbush analysts kept an Outperform rating and raised their price target to $28, reflecting confidence in the data. The news comes as the stock trades near its 52‑week high, with analyst consensus targets averaging $34.83.
Transaction History
| SDGR | ▲ Buy | Grant | 8,141 | $0 | 6/22/2026 | View on chart |
| PRAX | ▲ Buy | Grant | 1,371 | $0 | 6/10/2026 | View on chart |
| SDGR | ▲ Buy | Grant | 5,997 | $0 | 6/18/2025 | View on chart |
| ACET | ▲ Buy | Grant | 5,900 | $0 | 6/11/2025 | View on chart |
| SDGR | ▲ Buy | Grant | 5,000 | $0 | 6/18/2024 | View on chart |
| ACET | ▲ Buy | Grant | 5,900 | $0 | 6/5/2024 | View on chart |
| SDGR | ▲ Buy | Grant | 6,250 | $0 | 6/15/2023 | View on chart |
| ACET | ▲ Buy | Grant | 5,900 | $0 | 6/1/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Schrödinger (SDGR) Announces New Battery Research, Analyst Targets Rise
Schrödinger’s research team published a study in Nature that provides new insights into lithium‑ion battery chemistry, showcasing the company’s computational chemistry capabilities. Analyst houses TD Cowen and BMO Capital each lifted their price targets, citing the potential impact of the battery work and broader AI applications. At the same time, other analysts expressed mixed views on the company’s AI growth, resulting in a modest upward adjustment to its fair‑value estimate.
Schrödinger (SDGR) Announces New Battery Research, Analyst Targets Rise. Schrödinger’s research team published a study in Nature that provides new insights into lithium‑ion battery chemistry, showcasing the company’s computational chemistry capabilities. Analyst houses TD Cowen and BMO Capital each lifted their price targets, citing the potential impact of the battery work and broader AI applications. At the same time, other analysts expressed mixed views on the company’s AI growth, resulting in a modest upward adjustment to its fair‑value estimate.